📖 Approx. 10 min
In recent years, M&A has gained attention as an option for business succession in the medical industry. Particularly, driven by issues such as a lack of successors and the need to maintain regional healthcare, M&A of clinics and hospitals is on the rise. However, compared to general corporate M&A, medical M&A is an extremely complex process requiring specialized knowledge across various fields, including medical law, physician law, and the medical fee reimbursement system. While direct negotiation or succession negotiation by oneself is possible, utilizing a specialized intermediary company can increase the likelihood of overcoming complexities and achieving a more successful M&A.
The Complexity and Need for Specialized Knowledge Unique to Medical M&A
M&A of medical institutions is distinct from a mere sale or purchase of a business. One of the primary reasons for this is the unique organizational structure of medical corporations. Medical corporations are broadly categorized into “medical corporations with equity shares” and “medical corporations without equity shares,” and the schemes for succession or sale, as well as their tax implications, differ significantly between them. For medical corporations with equity shares, the focus is on the change of members (shareholders) and the valuation and transfer of equity shares. For medical corporations without equity shares, M&A typically proceeds through the return of funds and the change of the representative director, along with the transfer of medical equipment and real estate.
Types of Medical Corporations and Their Succession Characteristics
- Medical Corporations with Equity Shares: Often found in older medical institutions, these have equity shares with asset value, potentially making them subject to capital gains tax. The process primarily involves changing members (shareholders).
- Medical Corporations Without Equity Shares (e.g., Fund Contribution Type): Since there are no equity shares with asset value, M&A typically involves a change of the representative director and the transfer of assets such as medical equipment and clinic real estate. The return of funds depends on the articles of incorporation and the corporation’s financial status.
To understand these differences and construct an appropriate scheme, deep knowledge of medical law and tax law is essential. Furthermore, trends in medical fee revisions, compliance with facility standards, and the possibility of transferring licenses and permits significantly impact the success and terms of M&A.
The Value of “Optimal Matching” Provided by Intermediary Companies
One of the greatest benefits of using a medical M&A intermediary company is the “optimal matching” based on their extensive network and specialized knowledge. When searching for buyers or sellers independently, the scope is often limited. The medical industry, in particular, is highly regional, and needs for specific specialties or in certain areas can be quite unique. Intermediary companies broaden the pool of potential candidates and excel at finding the ideal partner for both parties, considering not only financial terms but also non-financial aspects such as management philosophy, treatment policies, and commitment to regional healthcare.
For example, it is crucial for the seller to find a buyer who understands and can appropriately inherit the medical institution’s philosophy and patient base that they have built. On the other hand, the buyer needs to efficiently find a medical institution that aligns with their expertise and future vision. Intermediary companies are adept at understanding these complex requirements, objectively listing potential candidates that could meet the needs of both parties, and acting as a bridge to facilitate initial negotiations.
| Item | Using an M&A Intermediary Company | Independent / Direct Negotiation |
|---|---|---|
| Matching Scope | Selection of optimal candidates from a broad network | Often limited to acquaintances and contacts |
| Negotiation Expertise | Support with specialized knowledge in medical M&A | Dependent on the knowledge and experience of the parties involved |
| Information Gathering & Analysis | Objective perspective and data-based evaluation | Prone to subjective and emotional involvement |
| Time & Effort | Negotiations and procedures are handled, allowing focus on core business | Requires significant time and effort |
| Risk Management | Identification and mitigation of legal and tax risks in advance | Risk of problems due to oversight |
Facilitating Complex Negotiation Processes and Adjusting Terms
Medical M&A progresses through various stages, from the initial expression of intent to the final agreement. It is not uncommon for disagreements between management or gaps in terms to arise at each stage. Intermediary companies play a role in facilitating negotiations by acting as neutral third parties, organizing the claims of both sides, and proposing realistic solutions. Particularly in the valuation of medical institutions, factors such as future revenue fluctuations due to medical fee revisions, costs of maintaining facility standards, and positioning within regional healthcare plans are complexly intertwined with past treatment performance, making specialized expertise indispensable. Intermediary companies comprehensively evaluate these factors and support fair and satisfactory adjustments to terms.
For instance, the ability to coordinate a wide range of terms, including not only the transfer price but also employee retention, post-transfer treatment policies, and handover periods, while maximizing the satisfaction of both parties to find common ground, is key to M&A success. Intermediary companies lead these processes, avoiding emotional conflicts and guiding rational decision-making, thereby reducing the risk of negotiations breaking down mid-way.
- Initial Consultation & NDA Signing: Begin sharing specific information with the intermediary company.
- Medical Institution Valuation & Term Clarification: Evaluate from multiple perspectives (financial, legal, treatment) and clarify transfer terms.
- Search & Selection of Buyer Candidates: List optimal candidates from the intermediary’s network.
- Letter of Intent (LOI) Submission & Negotiation: Begin negotiations towards a basic agreement based on the terms proposed by the buyer candidate.
- Due Diligence (DD) Execution: The buyer extensively investigates the medical institution’s legal, financial, tax, labor, and regulatory compliance status.
- Final Term Negotiation & Final Agreement Signing: Based on DD results, agree on final transfer terms and sign the contract.
- Closing & Succession Procedures: Complete post-M&A procedures such as payment, license changes, and member changes.
Specialized Due Diligence and Risk Management
Due diligence (DD) is a critical process in M&A. For medical M&A, specialized DD is essential to identify risks unique to medical institutions, in addition to general financial and legal DD. This includes detailed investigations into the appropriateness of past medical fee claims, risks of medical malpractice lawsuits, maintenance status of medical equipment, compliance with facility standards, employment contracts and retirement benefit plans for medical professionals such as doctors and nurses, and records of guidance or audits from regional public health centers and bureaus. Any deficiencies in these areas could lead to unexpected administrative guidance or additional costs after the succession, significantly diminishing the M&A’s value.
Key Due Diligence Items in Medical M&A
- Financial DD: Profitability, cost structure, presence of off-balance sheet liabilities, asset valuation (medical equipment, real estate, etc.).
- Legal DD: Compliance with medical law, physician law, pharmaceutical and medical device law, etc., validity of licenses, patient information management system, medical malpractice risks.
- Labor DD: Employment contracts for doctors, nurses, etc., working hours, wage regulations, retirement benefit systems, harassment prevention measures.
- Medical Fee DD: Appropriateness of past medical fee claims, compliance with facility standards, audit history.
- Business DD: Regional medical needs, competitive landscape, patient demographics, alignment with future growth strategies.
Intermediary companies coordinate with external specialists such as lawyers, certified public accountants, and tax accountants familiar with medical law to facilitate these specialized DD processes. This allows the seller to understand potential risks associated with their medical institution in advance, and the buyer to correctly assess risks and set appropriate transfer terms. Risk management by intermediary companies is indispensable for preventing post-M&A issues and ensuring a secure transaction for both parties.
Tax and Legal Optimization and Support for Post-Succession Stability
Specialized knowledge of tax and legal matters is particularly important in medical M&A. For example, there are various tax issues, such as capital gains tax associated with the transfer of equity shares upon the change of members in a medical corporation, consumption tax treatment in business transfers, and taxes related to real estate transfer registrations. Errors in these tax treatments can lead to unexpected and substantial tax liabilities. In collaboration with affiliated tax accountants, intermediary companies propose M&A schemes that minimize tax burdens while remaining legally sound, thereby optimizing tax implications.
Furthermore, legally, numerous procedures are required, including the change of representative director for medical corporations, various notifications to public health centers, applications for clinic establishment/discontinuation, and contracts for the transfer of medical equipment. These procedures have strict deadlines and requirements, and deficiencies can hinder business continuity. Intermediary companies appropriately navigate these legal procedures, supporting a smooth start for the business after succession. Additionally, soft aspects such as employee transition, patient communication, and community outreach are essential for stable post-succession management. Intermediary companies support both sellers and buyers throughout this entire process, leading to the true success of the M&A.
Tax and Legal Checkpoints in Medical M&A
- ✅ Presence and calculation method of capital gains tax according to the type of medical corporation.
- ✅ Consideration of consumption tax, real estate acquisition tax, registration license tax, etc., in business transfers.
- ✅ Procedures for amending the articles of incorporation of medical corporations, changing officers, and transferring membership.
- ✅ Administrative procedures such as clinic establishment permits, change permits, and discontinuation notifications.
- ✅ Transfer of ownership of medical equipment and continuation of lease agreements.
- ✅ Transfer of employment contracts for employees and confirmation of working conditions.
- ✅ Proper handover of patient information and compliance with personal information protection laws.
Reduction of Time and Effort, and Focus on Core Business
The medical M&A process is highly complex and requires significant time and effort. It is particularly challenging for executives to manage M&A alongside their busy clinical duties. By using an M&A intermediary company, all M&A-related tasks, such as searching for matching parties, preparing documents, negotiating, coordinating due diligence, and drafting contracts, can be delegated to specialists. This allows executives to substantially reduce the time and effort spent on the M&A process and focus on their primary responsibilities: patient care and the operation of the medical institution.
Maintaining the quality of the medical institution and ensuring uninterrupted patient service during the M&A process is extremely important. By having the intermediary company handle the practical tasks, executives are freed from mental burdens, contributing not only to the success of the M&A but also to the maintenance of daily clinical quality. Delegating to specialists ensures a smoother and more efficient M&A process, ultimately contributing to an increased probability of success.
How to Choose an M&A Intermediary Company Without Failure
To ensure the success of a medical M&A, choosing the right intermediary company is crucial. Here are some key points to consider when selecting the best partner from the many M&A intermediary companies available:
- Specialization and Track Record in the Medical Industry: Given the unique nature of medical M&A, it is essential to choose an intermediary company with specialized knowledge of the medical industry and a proven track record. Reviewing past successful cases and their experience with different types of medical corporations is advisable.
- Quality and Reliability of the Representative: M&A is a long-term process, and a trusting relationship with the representative is indispensable. Assess their expertise in medical and tax law, communication skills, and commitment to confidentiality during meetings.
- Transparency of Fee Structure: The structure of intermediary fees (retainer, interim, success fee, etc.) varies by company. Obtain a clear explanation in advance and confirm that the fee structure is acceptable. Even with a success fee model, the basis for its calculation should be clear.
- Certification as an M&A Support Institution by the Small and Medium Enterprise Agency: Certification, such as that held by CentralMedience Inc., indicating that the company meets the criteria set by the Small and Medium Enterprise Agency and provides appropriate M&A support, can be a reliable indicator.
- Information Management System and Confidentiality Obligations: As sensitive information such as patient and business data is handled, it is essential to confirm a strict information management system and the thoroughness of confidentiality obligations.
By meeting with and comparing multiple intermediary companies, you can find a partner that best meets your institution’s needs and with whom you can confidently entrust the process. Proceeding with selection without haste is the first step towards a successful M&A.
For clinic directors and medical corporation chairpersons, medical M&A represents a significant decision point. To facilitate this complex process smoothly and achieve the best outcome, support from an M&A intermediary company with specialized knowledge and extensive experience in the medical industry is indispensable. At M&A Medical (operated by CentralMedience Inc.), our specialists, who deeply understand the characteristics of medical institutions, offer optimal M&A strategies tailored to each client’s situation. We also offer free consultations, so please feel free to contact us.
For Medical Succession Consultations, Contact M&A Medical
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support everything from the transfer of clinics and medical corporations facing successor shortages to strategic acquisitions on a success-fee basis.
- Initial consultation and preliminary assessment are free.
- No retainer or monthly fees (success fee only).
- Strict confidentiality (proceeds after NDA signing).
- Service available nationwide across all 47 prefectures and all medical specialties.
Please consult with us early, even in the initial stages of consideration, whether you simply want to know the market value, have no successor, or are considering joining a group.